Back
Phathom Pharmaceuticals Stock Price Chart

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
16
PHAT
Phathom Pharmaceuticals
Last Price:
$4.06
Seasonality Move:
6.22%
7 Day Trial
ALL ACCESS PASS
$
7

This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.
Phathom Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.42 | Sell |
20-day SMA: | 5.29 | Sell |
50-day SMA: | 5.44 | Sell |
200-day SMA: | 10.53 | Sell |
8-day EMA: | 4.51 | Sell |
20-day EMA: | 4.95 | Sell |
50-day EMA: | 5.66 | Sell |
200-day EMA: | 8.76 | Sell |
Phathom Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.4 | Sell |
Relative Strength Index (14 RSI): | 38.03 | Sell |
Chaikin Money Flow: | -887882 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.44 - 6.2) | Sell |
Bollinger Bands (100): | (5.16 - 8.08) | Sell |
Phathom Pharmaceuticals Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 4.03 while PHAT 8-day simple moving average is 4.42, which is a Sell signal.
-
The stock price of PHAT is 4.03 while Phathom Pharmaceuticals 20-day SMA is 5.29, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day simple moving average is 5.44 while PHAT share price is 4.03, making it a Sell technically.
-
PHAT stock price is 4.03 and Phathom Pharmaceuticals 200-day simple moving average is 10.53, creating a Sell signal.
PHAT Technical Analysis vs Fundamental Analysis
Sell
16
Phathom Pharmaceuticals (PHAT)
is a Sell
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a SellThe current Phathom Pharmaceuticals [PHAT] share price is $4.03. The Score for PHAT is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
280.6M
Price in USD:
4.03
Share Volume:
956.2K
Phathom Pharmaceuticals 52-Week Range
52-Week High:
19.71
52-Week Low:
3.81
Sell
16
Phathom Pharmaceuticals (PHAT)
is a Sell
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?The Phathom Pharmaceuticals stock price is 4.03 USD today.
-
Will PHAT stock go up or go down?Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Phathom Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 4.03 while PHAT 8-day exponential moving average is 4.51, which is a Sell signal.
-
The stock price of PHAT is 4.03 while Phathom Pharmaceuticals 20-day EMA is 4.95, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day exponential moving average is 5.66 while PHAT share price is 4.03, making it a Sell technically.
-
PHAT stock price is 4.03 and Phathom Pharmaceuticals 200-day simple moving average is 8.76, creating a Sell signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.22 per share, an increase this year of $0.78 per share, and an increase next year of $2.19 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
-
PHAT Moving Average Covergence Divergence (MACD) indicator is -0.4, suggesting Phathom Pharmaceuticals is a Sell
-
Phathom Pharmaceuticals Relative Strength Index (RSI) is 38.03, which suggest Phathom Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Phathom Pharmaceuticals is (4.44 - 6.2), which suggest Phathom Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Phathom Pharmaceuticals is (5.16 - 8.08), which suggest Phathom Pharmaceuticals is a Sell
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.